Price of creon?

How Much Does Creon Cost Without Insurance?

Creon is a pancreatic enzyme replacement therapy (PERT) medication that helps treat pancreatic insufficiency, a condition where the pancreas doesn't produce enough digestive enzymes. The cost of Creon can vary depending on the dosage strength, quantity, and pharmacy location.

A vial of Creon that contains 3,000 to 10,000 lipase units costs around $500 to $600 without insurance [1]. However, prices may exceed $1,000 for higher-strength formulas or larger quantity packs. Patients should check with their insurance provider and pharmacy to determine the exact cost and any possible savings or discounts.

Comparison with Other Pancreatic Enzyme Supplements

Creon is often compared to other pancreatic enzyme supplements like Pancreaze and Zenpep. While the prices of these medications vary, a study found that the average wholesale price of Creon (12,000 lipase units) was around $1,400, which is higher than Pancreaze ($900) and Zenpep ($600) [2].

Discounts and Coupons

Patients may be able to reduce the cost of Creon through various discounts and coupons. These can be found on pharmaceutical company websites, patient advocacy groups, or by searching online for Creon coupon codes. Additionally, some online pharmacies offer discounts or generic alternatives.

Generic Version Availability

The generic version of Creon, which is manufactured by Takeda Pharmaceuticals, is also available and may be less expensive than the brand-name version. The generic formula is designed to replicate the same enzyme activity as the original Creon.

When Does Exclusivity Expire?

The patent for Creon is set to expire in 2034, although generic versions are already available. This may lead to further price competition and potential savings for patients.

What to Do if You're Affected by High Costs

Patients struggling to afford Creon or other essential medications can explore options such as:

* Non-profit patient assistance programs
* Insurance coverage or Medicare Part D
* Medicaid or government assistance programs
* Discounted generics or biosimilars

Sources:

[1] DrugPatentWatch.com
[2] ResearchGate